FDA Asks Whether Supplement Industry Has Outgrown Regulatory Framework
Executive Summary
Commissioner Gottlieb appointed working group at FDA to evaluate agency's existing structure and strategies for oversight of supplement sector. Group's findings will determine extent of potential changes in regulatory authorities agency will ask members of Congress to establish through legislation. Action plan expected in early 2019.
You may also be interested in...
Modernizing FDA's Supplement Industry Regulation Mapped Out In Five-Point Plan
Commissioner Scott Gottlieb announces FDA's plan for policy changes to implement "one of the most significant modernizations of dietary supplement regulation and oversight in more than 25 years." Plan includes steps to ensure its regulatory framework is flexible enough to adequately evaluate product safety while also promoting innovation, particularly finalizing NDI notifications guidance and fostering submissions of the notifications.
FDA Regulatory Oversight No Impediment To Drug-Spiked Supplements, Study Finds
Products marketed for sexual enhancement or weight loss remain the most common types that contain undeclared drug ingredients,but drugs are showing up less in a third type that had been frequently found with drugs, bodybuilding supplements, says study in Journal of the American Medical Association. Researchers analyzing FDA database of tainted products marketed as supplements, say the trend didn't slow as FDA increased its GMP inspections and issued numerous warning letters.
'Big Shoes To Fill' As Hatch Retirement Leaves Supplement Market Legacy
Sen. Orrin Hatch won’t seek re-election and will leave 24 years after Congress passed the Dietary Supplement Health and Education Act as a framework for FDA's regulation of vitamin, mineral and supplement product manufacturing and marketing. Hatch is in his seventh term and is the longest-serving Senate member.